Gloria Matthews, Ankasa Regenerative Technologies - Novel Regenerative Medicine | LSI USA '24

Ankasa is developing ART352-L as a novel regenerative medicine. ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries.
Speakers
Gloria Matthews
Gloria Matthews
Ankasa Regenerative Technologies